Statistics for Neurones (id:10702 NRO)

Valuation metrics

Market cap

1.12B

Enterprise value

943.17M

Trailing P/E (ttm)

23.12

Forward P/E

20.91

PEG ratio

20.91

Price/Sales (ttm)

1.45

Price/Book (mrq)

3.19

Enterprise Value/Revenue

1.22

Enterprise Value/EBITDA

11.48

Overview

Shares outstanding

24.27M

Float

8.80M

Shares short

% Held by insiders

0.70%

% Held by institutions

0.13%

Average volume (10 days)

10.38K

Average volume (90 days)

Price summary

52-Week low

37.35

52-Week high

48.15

52-Week change

15.67%

Beta

0.56

50-Day moving average

44.44

200-Day moving average

44.52

Dividends and splits

Forward annual dividend rate

4.80

Forward annual dividend yield

0.11

Trailing annual dividend rate

1.20%

Trailing annual dividend yield

0.03

5-Year annual dividend yield

0.38

Payout ratio

0.60

Dividend date

Ex-dividend date

June 12th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

6.26%

Operating margin

9.19%

Operational effectiveness

Return on assets

7.06%

Return on equity

14.87%

Income statement

Revenue (ttm)

31.94

Revenue per share (ttm)

31.94

Quarterly revenue growth (yoy)

-0.04

Gross profit (ttm)

457.51M

EBITDA

97.37M

Net income to common (ttm)

48.49M

Diluted EPS (ttm)

1.99

Quarterly earnings growth (yoy)

-3.60%

Balance sheet

Total cash (mrq)

268.12M

Total cash per share (mrq)

11.04

Total debt (mrq)

46.73M

Total Debt/Equity (mrq)

11.71

Current ratio (mrq)

224.50%

Book value per share (mrq)

14.41

Cash flow

Cash flow statement

62.18M

Levered free cash flow (LFCF)

42.64M